T. Rowe Price Associates’s Collegium Pharmaceutical COLL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.07M Buy
36,263
+1,725
+5% +$51K ﹤0.01% 1958
2025
Q1
$1.03M Buy
34,538
+1,400
+4% +$41.8K ﹤0.01% 1941
2024
Q4
$950K Buy
33,138
+1,977
+6% +$56.7K ﹤0.01% 1985
2024
Q3
$1.21M Buy
31,161
+300
+1% +$11.6K ﹤0.01% 1892
2024
Q2
$994K Buy
30,861
+1,579
+5% +$50.9K ﹤0.01% 1896
2024
Q1
$1.14M Buy
29,282
+535
+2% +$20.8K ﹤0.01% 1858
2023
Q4
$885K Buy
28,747
+766
+3% +$23.6K ﹤0.01% 1922
2023
Q3
$626K Buy
27,981
+1,011
+4% +$22.6K ﹤0.01% 2002
2023
Q2
$580K Buy
26,970
+422
+2% +$9.08K ﹤0.01% 2049
2023
Q1
$637K Sell
26,548
-1,713
-6% -$41.1K ﹤0.01% 2004
2022
Q4
$656K Buy
28,261
+669
+2% +$15.5K ﹤0.01% 2001
2022
Q3
$443K Buy
27,592
+2,012
+8% +$32.3K ﹤0.01% 2177
2022
Q2
$453K Buy
25,580
+1,425
+6% +$25.2K ﹤0.01% 2252
2022
Q1
$492K Buy
24,155
+2,108
+10% +$42.9K ﹤0.01% 2338
2021
Q4
$412K Sell
22,047
-600
-3% -$11.2K ﹤0.01% 2477
2021
Q3
$447K Sell
22,647
-100
-0.4% -$1.97K ﹤0.01% 2424
2021
Q2
$538K Sell
22,747
-3,058
-12% -$72.3K ﹤0.01% 2354
2021
Q1
$612K Buy
25,805
+4,832
+23% +$115K ﹤0.01% 2271
2020
Q4
$420K Sell
20,973
-106
-0.5% -$2.12K ﹤0.01% 2308
2020
Q3
$439K Buy
21,079
+7,300
+53% +$152K ﹤0.01% 2140
2020
Q2
$241K Buy
13,779
+211
+2% +$3.69K ﹤0.01% 2314
2020
Q1
$222K Sell
13,568
-82,560
-86% -$1.35M ﹤0.01% 2282
2019
Q4
$1.98M Buy
96,128
+63,776
+197% +$1.31M ﹤0.01% 1605
2019
Q3
$371K Buy
32,352
+190
+0.6% +$2.18K ﹤0.01% 2203
2019
Q2
$423K Buy
32,162
+65
+0.2% +$855 ﹤0.01% 2168
2019
Q1
$486K Buy
32,097
+100
+0.3% +$1.51K ﹤0.01% 2116
2018
Q4
$549K Sell
31,997
-10,265
-24% -$176K ﹤0.01% 2036
2018
Q3
$623K Buy
+42,262
New +$623K ﹤0.01% 2060
2018
Q2
Sell
-67,285
Closed -$1.72M 2573
2018
Q1
$1.72M Buy
67,285
+3,478
+5% +$88.9K ﹤0.01% 1614
2017
Q4
$1.18M Buy
+63,807
New +$1.18M ﹤0.01% 1722